469 related articles for article (PubMed ID: 20400818)
1. Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide.
Chen YS; Hung YC; Lin WH; Huang GS
Nanotechnology; 2010 May; 21(19):195101. PubMed ID: 20400818
[TBL] [Abstract][Full Text] [Related]
2. Gold nanoparticles regulate the blimp1/pax5 pathway and enhance antibody secretion in B-cells.
Lee CH; Syu SH; Chen YS; Hussain SM; Aleksandrovich Onischuk A; Chen WL; Steven Huang G
Nanotechnology; 2014 Mar; 25(12):125103. PubMed ID: 24576992
[TBL] [Abstract][Full Text] [Related]
3. Synthetic peptides against foot-and-mouth disease--immunization with VP1-peptides of type O1-Kaufbeuren.
Liebermann H; Holl U; Reimann I; Nöckler A; Schäfer D; Thalmann G; Dölling R
Arch Exp Veterinarmed; 1990; 44(6):883-90. PubMed ID: 1966360
[TBL] [Abstract][Full Text] [Related]
4. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant effect of Cliptox on the protective immune response induced by an inactivated vaccine against foot and mouth disease virus in mice.
Batista A; Quattrocchi V; Olivera V; Langellotti C; Pappalardo JS; Di Giacomo S; Mongini C; Portuondo D; Zamorano P
Vaccine; 2010 Aug; 28(38):6361-6. PubMed ID: 20637310
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of synthetic peptide vaccines against foot-and-mouth disease type A].
Tang H; Liu X; Fang Y; Jiang S; Pan L; Lv J; Zhang Z; Zhou P; Zhang Y; Wang Y
Wei Sheng Wu Xue Bao; 2013 Jun; 53(6):596-607. PubMed ID: 24028062
[TBL] [Abstract][Full Text] [Related]
7. Identification of a major antibody binding epitope in the non-structural protein 3D of foot-and-mouth disease virus in cattle and the development of a monoclonal antibody with diagnostic applications.
Yang M; Clavijo A; Li M; Hole K; Holland H; Wang H; Deng MY
J Immunol Methods; 2007 Apr; 321(1-2):174-81. PubMed ID: 17320098
[TBL] [Abstract][Full Text] [Related]
8. Size-dependent impairment of cognition in mice caused by the injection of gold nanoparticles.
Chen YS; Hung YC; Lin LW; Liau I; Hong MY; Huang GS
Nanotechnology; 2010 Dec; 21(48):485102. PubMed ID: 21051801
[TBL] [Abstract][Full Text] [Related]
9. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
[TBL] [Abstract][Full Text] [Related]
10. A proposal for an alternative quality control test procedure for inactivated vaccines against food-and-mouth disease virus.
Molin-Capeti KC; Sepulveda L; Terra F; Torres-Pioli MF; Costa-Casagrande T; França SC; Thomaz-Soccol V
Vaccine; 2013 Feb; 31(9):1349-52. PubMed ID: 23267841
[TBL] [Abstract][Full Text] [Related]
11. Extract from Agaricus blazei Murill can enhance immune responses elicited by DNA vaccine against foot-and-mouth disease.
Chen L; Shao H
Vet Immunol Immunopathol; 2006 Jan; 109(1-2):177-82. PubMed ID: 16213597
[TBL] [Abstract][Full Text] [Related]
12. Correlation between the composition of multivalent antibody conjugates with colloidal gold nanoparticles and their affinity.
Safenkova IV; Zherdev AV; Dzantiev BB
J Immunol Methods; 2010 May; 357(1-2):17-25. PubMed ID: 20347832
[TBL] [Abstract][Full Text] [Related]
13. [Antigenic structure of the foot-and-mouth disease virus. II. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth disease virus type A22].
Vol'pina OM; Surovoĭ AIu; Ul'iashin VV; Ivanov VT; Chepurkin AV
Bioorg Khim; 1988 Oct; 14(10):1363-71. PubMed ID: 2852938
[TBL] [Abstract][Full Text] [Related]
14. Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus.
Li YG; Tian FL; Gao FS; Tang XS; Xia C
Vaccine; 2007 Jan; 25(5):902-11. PubMed ID: 17028078
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
[TBL] [Abstract][Full Text] [Related]
16. Optimization strategy for plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus by cis-expression with IL-2.
Zhang HY; Sun SH; Guo YJ; Zhu WJ; Shi K; Xu GX; Wang JJ
Vaccine; 2008 Feb; 26(6):769-77. PubMed ID: 18191307
[TBL] [Abstract][Full Text] [Related]
17. Florfenicol impairs the immune responses to vaccination against foot-and-mouth disease in mice.
Guan S; Lu J; Shen X; Qian W; Liu J; Deng X
Immunopharmacol Immunotoxicol; 2011 Dec; 33(4):609-13. PubMed ID: 21428714
[TBL] [Abstract][Full Text] [Related]
18. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
Zheng M; Jin N; Zhang H; Jin M; Lu H; Ma M; Li C; Yin G; Wang R; Liu Q
J Virol Methods; 2006 Sep; 136(1-2):230-7. PubMed ID: 16780963
[TBL] [Abstract][Full Text] [Related]
19. RNA immunization can protect mice against foot-and-mouth disease virus.
Pulido MR; Sobrino F; Borrego B; Sáiz M
Antiviral Res; 2010 Mar; 85(3):556-8. PubMed ID: 20005905
[TBL] [Abstract][Full Text] [Related]
20. Development of Tobacco necrosis virus A as a vector for efficient and stable expression of FMDV VP1 peptides.
Zhang Y; Li J; Pu H; Jin J; Zhang X; Chen M; Wang B; Han C; Yu J; Li D
Plant Biotechnol J; 2010 May; 8(4):506-23. PubMed ID: 20331532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
